| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Athira Pharma, Inc. | CFO and Chief Business Officer | Common Stock | 97.5K | $55.2K | $0.57 | Sep 5, 2024 | Direct |
| Athira Pharma, Inc. | CFO and Chief Business Officer | Stock Option (Right to Buy) | 280K | Feb 14, 2024 | Direct | ||
| Cyteir Therapeutics, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 35K | Feb 22, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | Sep 3, 2024 | 3 | $12.7K | 4 | Sep 5, 2024 | CFO and Chief Business Officer |
| ATHA | Athira Pharma, Inc. | Feb 14, 2024 | 1 | $0 | 4 | Feb 16, 2024 | CFO AND CHIEF BUSINESS OFFICER |
| ATHA | Athira Pharma, Inc. | Jan 4, 2024 | 2 | -$3.52K | 4/A | Feb 16, 2024 | CFO AND CHIEF BUSINESS OFFICER |
| ATHA | Athira Pharma, Inc. | Jan 4, 2024 | 2 | -$3.52K | 4 | Jan 8, 2024 | Officer |
| ATHA | Athira Pharma, Inc. | Jun 7, 2023 | 3 | $51.4K | 4 | Jun 9, 2023 | Officer |
| ATHA | Athira Pharma, Inc. | Jun 2, 2023 | 7 | $192K | 4 | Jun 6, 2023 | Officer |
| ATHA | Athira Pharma, Inc. | May 18, 2023 | 1 | $0 | 4 | May 22, 2023 | Officer |
| ATHA | Athira Pharma, Inc. | May 18, 2023 | 0 | $0 | 3 | May 22, 2023 | Officer |
| CYT | Cyteir Therapeutics, Inc. | Feb 22, 2022 | 1 | $0 | 4 | Feb 24, 2022 | Chief Business Officer |
| CYT | Cyteir Therapeutics, Inc. | Jun 17, 2021 | 0 | $0 | 3 | Jun 17, 2021 | Chief Business Officer |